Granulomatosis with polyangiitis (GPA) (previously known as Wegener’s disease) is a rare autoimmune disease that causes inflammation of blood vessels in various body parts. It primarily affects the respiratory system but can also impact the kidneys, skin, and nervous system.
The exact cause of GPA is not fully understood, but genetics are believed to play a role in its development. Certain genetic variations have been linked to an increased risk of developing GPA. Environmental factors such as exposure to certain chemicals or infections may trigger the predisposed immune system to attack healthy tissues.
The symptoms of GPA can vary depending on which organs or systems are affected but often include coughing, wheezing, shortness of breath, fever, joint pain, and skin rashes. In some cases, GPA can lead to serious complications, such as kidney failure or nerve damage.
Diagnosis of GPA typically involves a combination of a physical exam, blood tests, imaging studies, and possibly a biopsy of the affected tissue. Treatment may involve medications to suppress the immune system and reduce inflammation, as well as management of any complications that arise.
It's important to seek medical attention if you experience any GPA symptoms. Early diagnosis and treatment can help manage symptoms and prevent complications. Knowing your genetic predisposition may increase your awareness of the symptoms of GPA and enable you to get an earlier diagnosis to get treatment.
In conclusion, GPA is a rare autoimmune disease that primarily affects the respiratory system but can also impact other organs and systems. While the exact cause is not fully understood, genetics are believed to play a role in its development. Early recognition and prompt treatment can help manage symptoms and prevent complications.
Interested in trying the BioCertica DNA Autoimmune kit? Click here and add Autoimmune Diseases to your cart for only R1699.
If you own any other BioCertica DNA kit, you can instantly unlock your Autoimmune Disease results for only R659* in-app.
*Terms and conditions apply: Pharmacogenetics results are R1999 in-app.